Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Phase 2 Trial Recent news which mentions Phase 2 Trial < Previous 1 2 3 4 5 6 7 8 9 Next > Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials March 14, 2022 Tickers CLNN Tags Biotech CLNN Health Care From Benzinga BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market March 14, 2022 Tickers BBIO Tags News Health Care Trading Ideas From Benzinga Scholar Rock To Highlight Apitegromab Data From Ambulatory Cohort In Muscular Dystrophy March 14, 2022 Tickers SRRK Tags Market News Health Care SRRK From Benzinga Why Sanofi Shares Are Trading Lower Today March 14, 2022 Tickers SNY Tags SNY News Health Care From Benzinga Moderna Starts Dosing In Mid-Stage Omicron-Specific Bivalent Booster Candidate March 10, 2022 Tickers MRNA Tags News Benzinga Health Care From Benzinga FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients March 08, 2022 Tickers IVA Tags Benzinga Health Care IVA From Benzinga Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer February 17, 2022 Tickers ALKS Tags General Phase 2 Trial Briefs From Benzinga Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer February 15, 2022 Tickers AMGN Tags Market News News Pancreatic Cancer From Benzinga ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting February 15, 2022 Tickers ENDP IBRX MRK Tags Phase 2 Trial Small Cap General From Benzinga BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer February 15, 2022 Tickers BTAI MRK Tags BTAI Phase 2 Trial General From Benzinga Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration February 14, 2022 Tickers OPT Tags Age/Related Macular Degeneration Phase 2 Trial Market News From Benzinga RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial February 09, 2022 Tickers RGNX Tags Small Cap General Phase 2 Trial From Benzinga 4D Molecular Shares Updated Data From Fabry Disease Trial February 09, 2022 Tickers FDMT Tags General Small Cap Phase 2 Trial From Benzinga After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data February 09, 2022 Tickers AVRO Tags Phase 1 Trial Health Care Penny Stocks From Benzinga Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday? February 07, 2022 Tickers NLSP Tags Briefs Biotech Movers From Benzinga Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward February 04, 2022 Tickers PFE VALN Tags Health Care Benzinga Biotech From Benzinga Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity January 31, 2022 Tickers ALT Tags ALT Market News Trading Ideas From Benzinga Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target January 31, 2022 Tickers JNJ KLDO Tags General FDA Phase 2 Trial From Benzinga Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial January 27, 2022 Tickers TSHA Tags News TSHA Phase 1 Trial From Benzinga 4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy January 27, 2022 Tickers LBPS Tags Phase 2 Trial General Biotech From Benzinga Why Are Tyme Technologies Shares Staring At 52-Week Low January 26, 2022 Tickers TYME Tags General Phase 2 Trial Briefs From Benzinga Two Organizations To Support Wave Life Sciences' FTD, ALS Program January 26, 2022 Tickers WVE Tags WVE Contracts Market News From Benzinga Imara To Start Testing Tovinontrine In Heart Failure Patients January 25, 2022 Tickers IMRA Tags General Phase 2 Trial IMRA From Benzinga FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder January 25, 2022 Tickers FBIO MBIO Tags Phase 2 Trial General FDA From Benzinga 89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health January 25, 2022 Tickers ETNB Tags Phase 1 Trial Health Care ETNB From Benzinga Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA January 24, 2022 Tickers TNGX Tags Briefs Benzinga Movers From Benzinga On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial January 24, 2022 Tickers SABS Tags General Phase 2 Trial Market News From Benzinga MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers January 24, 2022 Tickers MDWD Tags Health Care Penny Stocks Benzinga From Benzinga Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients January 21, 2022 Tickers MRTX Tags Biotech Health Care Benzinga From Benzinga Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024 January 21, 2022 Tickers PRVB Tags Briefs PRVB Benzinga From Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
